Zum Hauptinhalt springen

Prevalence of low muscle mass and associated factors in community-dwelling older adults in Singapore

Yen Ling Low ; Cheong, Magdalin ; et al.
In: Scientific Reports, Jg. 11 (2021), Heft 1, S. 1-13
Online unknown

Prevalence of low muscle mass and associated factors in community-dwelling older adults in Singapore  Introduction

The population is rapidly aging worldwide, and there is an age-related decline in muscle mass. Therefore, it is important to examine the prevalence and associated factors of low appendicular skeletal muscle mass index (ASMI) in older adults. The objectives of this cross-sectional study were (i) to determine the prevalence of low ASMI (ASM/height2) and (ii) to identify factors associated with low ASMI. This study included 1211 community-dwelling adults aged ≥ 65 years. Low ASMI was defined as < 7.0 kg/m2 in males and < 5.7 kg/m2 in females (bioelectrical impedance analysis). Gender-specific cut-off values of calf circumference for low ASMI were determined. The prevalence of low ASMI in the overall cohort was 59.9%, i.e., 57.0% among males and 61.8% among females, with no significant difference between genders (P = 0.1068). The prevalence of low ASMI was 81.3% in individuals at risk of malnutrition compared to 20.6% in their counterparts with normal nutritional status (P < 0.0001). Participants with low ASMI were older, had lower physical activity scores, and greater likelihood of hospitalization in prior 6 months compared with normal ASMI (all P < 0.0001). Low ASMI was associated with risk of malnutrition (odds ratio: 3.58 for medium risk, odds ratio: 12.50 for high risk), older age, smoking, drinking, smaller calf circumference, and lower bone mass (all P ≤ 0.0328). Cut-off values of calf circumference for low ASMI for males was 33.4 cm and for females was 32.2 cm. In conclusion, we found that low ASMI was highly prevalent among community-dwelling older adults at risk of malnutrition. Other significant factors associated with low ASMI were age, smoking, drinking, calf circumference, and bone mass. Screening community-dwelling older adults for risk of malnutrition can prevent or delay onset of low ASMI.

Aging is associated with physiological decline in skeletal muscle mass, which can escalate the tolls on overall health and function, and may ultimately increase risk of death[1]–[3]. Across Asia, low muscle mass is reported to occur commonly in community-dwelling older adults[4]–[8], ranging from 20 to 63%. It is also known that women have lower muscle mass than men[9]. Since age-related muscle decline occurs in both women and men, women remain to have lower muscle mass than men in older age[10]–[13]. Thus, gender-specific measurements and cut-offs are important for more accurate identifications of low muscle mass, especially for surrogate marker of muscle mass such as calf circumference.

Factors predisposing older adults to poor muscle health are low socio-economic status, underlying chronic diseases, poor nutritional intake, and adverse lifestyle (Fig. 1). Socio-economic deprivation includes low income and low education level[14],[15]. Chronic diseases which can increase the risk of muscle decline include diabetes and chronic obstructive pulmonary disease[16],[17]. In addition, acute illness or injury can initiate a cascade ultimately leading to poor muscle health[18]. In older adults, anorexia of aging is associated with low muscle mass and strength[19]. Lifestyle-related risks such as physical inactivity[20], smoking[21], and drinking[14] are also associated with poor muscle health.

Graph: Figure 1 Factors contributing to poor muscle health and its impact in older adults.

Older adults with evidence of low muscle mass are at high risk of adverse health outcomes such as reduced mobility, impaired ability to perform activities of daily living and lower quality of life, fall-related injuries, infections, hospitalization and need for long-term care[3],[4] (Fig. 1). A vicious cycle may then develop resulting in more loss of muscle mass, further disability, poorer health, ultimately leading to increased mortality risk[2],[3]. However, there is recognized heterogeneity in the literature findings on the impact of muscle mass on functional ability in older adults[22],[23].

In a recent narrative review, low muscle mass or sarcopenia was consistently predictive of higher healthcare expenditure in community, perioperative, and general hospital settings[24]. In a study of older people in Taiwan, men and women with a lower skeletal muscle mass index (SMMI) had more hospitalizations, longer lengths of stay, and higher healthcare costs[25]. The annual difference in hospitalization costs between individuals with highest and lowest risk for low SMMI was equivalent to about United States dollars (USD) $1200 per patient year[25]. A United States study estimated direct healthcare costs for people with sarcopenia at 1.5% of the total annual healthcare expenditure, i.e., costs equivalent to USD $26.3 billion in 2020[26]. A more recent estimate of US costs for hospitalization in individuals with sarcopenia was USD $40.4 billion[27].

Singapore's population is growing older, similarly, but even faster than populations worldwide[28]. The global population of people ≥ 65 years has been projected to double from 703 million in 2019 to 1.5 billion by 2050[28]. Of this total, approximately 1.0 billion older adults will be living in Asia. In Singapore, the percentage of older adults is expected to double over the next decade from 12.4% in 2019 to 22.5% in 2030[28]. Thus, the objectives of this cross-sectional study were: (1) to determine the prevalence of low appendicular skeletal muscle mass index (ASMI; ASM/height[2]), and (2) to identify factors associated with low ASMI. The findings from this study may help to identify community-dwelling older adults at risk of low ASMI, in order to prevent and address the adverse consequences.

Methods

Study design and participants

Strengthening Health In ELDerly through nutrition (SHIELD) was a cross-sectional study of community-dwelling older adults in Singapore. Participants were recruited between August 2017 and March 2019. All procedures involving human subjects were approved by the Centralized Institutional Review Board in Singapore (reference number: 2017/2271). The present study was conducted according to the ethical standards laid down in the Declaration of Helsinki. Written informed consent was obtained from all participants. The trial was registered at clinicaltrials.gov as NCT03240952. The Nutritional Health for the Elderly Reference Centre (NHERC) is the name of the overarching project. One component of NHERC is the clinical trial, which is known as the SHIELD study.

A total of 1211 individuals consisting of 400 with normal nutritional status and 811 at risk of malnutrition took part in this study. The data for this study was derived from baseline measurements of two unique cohorts of the SHIELD study[29],[30]. Participants were recruited from the public, community centers, polyclinics, and hospitals through public talks, flyers, posters, and referrals from healthcare professionals.

Assessments

All study participants were asked to attend one visit at baseline, where the following data were collected.

Socio-demographic data such as age, gender, ethnicity, marital status, education, number of prescribed drugs, smoker status, and alcohol consumption were collected during the visit. Charlson Comorbidity Index was used to determine the comorbidity level[31],[32], and Malnutrition Universal Screening Test (MUST) was used to determine the risk of malnutrition[33].

Physical Activity Scale for the Elderly (PASE)[34],[35] was used to determine physical activity level and Modified Barthel Index (MBI)[36] was used to measure functional independence for ten activities of daily living.

For anthropometry and body composition measurements, standing height was measured without shoes by using a stadiometer to the nearest millimeter (Avamech B1000), and body weight and composition were measured to the nearest 0.1 kg using a bioelectrical impedance analysis (BIA) machine (Tanita MC-780). BIA was used to estimate muscle mass, fat mass, and bone mass. Mid upper arm circumference was measured at mid-point of the acromion and olecranon, and calf circumference was measured at the largest part of the calf. Both were measured to the nearest 0.1 cm.

Serum 25-hydroxyvitamin D levels were measured using immunochemistry analyzer COBAS e801 and vitamin D cut-off values were based on the definition described by Holick[37].

Healthcare utilization data on hospitalization and length of stay was collected using medical records and questionnaires if the former is unavailable.

Statistical analysis

Baseline characteristics of the study participants were reported as means and standard deviation (SD) for continuous variables, and numbers and percentages for categorical variables. For continuous variables, normality of the data was assessed using the Shapiro-Wilks test (P < 0.001) and graphical methods. Two-sample t test, Wilcoxon rank sum test, fisher exact test, and chi-square test were used to compare the characteristics between genders, nutritional status, and ASMI status. Low ASMI was determined based on BIA cut-offs recommended by the Asian Working Group for Sarcopenia (AWGS)[1], i.e., male < 7.0 kg/m2 and female < 5.7 kg/m2.

Multiple linear regression model was used to examine the associations between ASMI and all potential variables based on the literature. The adjusted R-square values measuring goodness of model fit were ≥ 0.6 for all the three models (overall cohort, males, and females). Multicollinearity between the predictors were tested using variance inflation factor and tolerance. The highest variance inflation factor (VIF) was bone mass with 3.6 VIF and the lowest tolerance was 0.3, which confirmed that there was no multicollinearity. Multiple logistic regression model was used to examine the associations between low ASMI and potential factors. Odds ratio and 95% confidence interval (CI) were estimated from logistic regression models.

Logistic regression and Receiver Operating Characteristics (ROC) method were used to determine the cut-off values for calf circumference associated with low ASMI in males and females. Kappa statistics was used to test the agreement between the cut-off values for low ASMI in the present study and the cut-off values for screening for sarcopenia recommended by the AWGS[1], i.e., male < 34 cm and female < 33 cm.

SAS version 9.4 (SAS Institute, Cary, NC, USA) was used for all statistical analyses. P < 0.0500 was considered statistically significant.

Institutional review board statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Centralized Institutional Review Board in Singapore of SingHealth (reference number: 2017/2271 and date of approval: 23 May 2017).

Informed consent statement

Informed consent was obtained from all subjects involved in the study.

Results

Participants' characteristics

Table 1 shows the characteristics of the overall cohort, males, and females. A total of 1211 older adults participated in this study. Mean (SD) age of participants was 73.20 (6.82) years and body mass index (BMI) was 20.43 (3.69) kg/m2. Most participants were Chinese (85.5%) and over 94% had a Charlson Comorbidity score of 0. More than half of the participants (57.0%) had either vitamin D deficiency or insufficiency. The prevalence of low ASMI in the overall cohort was nearly 60%, with no significant difference between genders (57.0% males vs. 61.8% females, P = 0.1068). Supplementary Table 1 shows the characteristics of older adults with normal nutritional status and at risk of malnutrition. The prevalence of low ASMI was 81.3% in older adults at risk of malnutrition and 20.6% for those with normal nutritional status (P < 0.0001).

Table 1 Characteristics of all participants.

Overall (n = 1211)

Males (n = 504)

Females (n = 707)

P Value (between genders)

Age (year)

73.20 (6.82)

73.39 (6.59)

73.06 (6.97)

0.4072

Ethnicity, n (%)

< 0.0001

Chinese

1036 (85.5)

404 (80.2)

632 (89.4)

Non-Chinese

175 (14.5)

100 (19.8)

75 (10.6)

Highest level of education, n (%)

0.0019

No formal education/primary

369 (30.6)

136 (27.0)

233 (33.1)

Secondary O/N level or equivalent

507 (42.0)

201 (39.9)

306 (43.5)

A level or equivalent

221 (18.3)

111 (22.0)

110 (15.6)

University and above

110 (9.1)

56 (11.1)

54 (7.7)

Smoking status, n (%)

< 0.0001

Non-smoker

946 (78.1)

277 (55.0)

669 (94.6)

Past smoker

175 (14.5)

153 (30.4)

22 (3.1)

Daily/occasional smoker

90 (7.4)

74 (14.7)

16 (2.3)

Alcohol consumption, n (%)

< 0.0001

Non-drinker

729 (60.2)

237 (47.0)

492 (69.6)

No drinks in last 12 months

210 (17.3)

117 (23.2)

93 (13.2)

< Once a month in last 12 months

157 (13.0)

67 (13.3)

90 (12.7)

≥ Once a month in last 12 months

115 (9.5)

83 (16.5)

32 (4.5)

Hospital admission in last 6 months, n (%)

0.0010

Yes

112 (9.3)

63 (12.5)

49 (6.9)

No

1098 (90.7)

441 (87.5)

657 (93.1)

Days admitted in hospital last 6 months

0.74 (3.86)

1.06 (4.77)

0.52 (3.02)

0.0008

Number of prescribed drugs, n (%)

0.0340

Nil (0)

300 (24.8)

118 (23.4)

182 (25.7)

One to five

697 (57.6)

280 (55.6)

417 (59.0)

More than five (> 5)

214 (17.7)

106 (21.0)

108 (15.3)

Physical Activity Scale for the Elderly score

109.05 (65.04)

112.77 (72.93)

106.40 (58.69)

0.1055

Modified Barthel Index score

98.71 (6.28)

98.92 (5.70)

98.56 (6.66)

0.3625

Modified Barthel Index, n (%)

0.7447

Severe dependence

9 (0.7)

3 (0.6)

6 (0.8)

Moderate dependence

38 (3.1)

13 (2.6)

25 (3.5)

Slight dependence

67 (5.5)

27 (5.4)

40 (5.7)

Independent

1097 (90.6)

461 (91.5)

636 (90.0)

Total Charlson Comorbidity score

0.06 (0.28)

0.10 (0.35)

0.04 (0.21)

0.0003

Charlson Comorbidity score, n (%)

0.0010

0

1142 (94.3)

461 (91.5)

681 (96.3)

1

62 (5.1)

38 (7.5)

24 (3.4)

2

5 (0.4)

3 (0.6)

2 (0.3)

3

2 (0.2)

2 (0.4)

0

25-hydroxyvitamin D (ug/L)

29.18 (9.69)

30.52 (10.13)

28.23 (9.26)

< 0.0001

25-hydroxyvitamin D, n (%)

0.0113

Deficient < 20 ug/L

203 (16.8)

67 (13.3)

136 (19.2)

Insufficient 20– < 30 ug/L

487 (40.2)

201 (40.0)

286 (40.5)

Sufficient 30–100 ug/L

520 (43.0)

235 (46.7)

285 (40.3)

Height (cm)

157.30 (8.82)

164.44 (6.50)

152.21 (6.40)

< 0.0001

Body weight (kg)

50.78 (11.02)

55.67 (11.12)

47.29 (9.53)

< 0.0001

BMI (kg/m2)

20.43 (3.69)

20.52 (3.58)

20.37 (3.76)

0.4900

Mid upper arm circumference (cm)

24.44 (3.62)

25.13 (3.41)

23.95 (3.69)

< 0.0001

Calf circumference (cm)

32.07 (3.70)

33.08 (3.55)

31.35 (3.65)

< 0.0001

Bone mass (kg)

2.10 (0.45)

2.44 (0.34)

1.87 (0.36)

< 0.0001

Appendicular skeletal muscle mass (kg)

15.38 (4.03)

18.95 (3.54)

12.96 (2.07)

< 0.0001

Appendicular skeletal muscle mass index (kg/m2)

6.14 (1.13)

6.97 (1.09)

5.58 (0.75)

< 0.0001

Low appendicular skeletal muscle mass index, n (%)

0.1068

Yes

676 (59.9)

260 (57.0)

416 (61.8)

No

453 (40.1)

196 (43.0)

257 (38.2)

BMI body mass index, O/N level Ordinary/normal level, A level advanced level. For continuous variables, results are presented as mean (standard deviation). For categorical variables, results are presented as number (%).

Characteristics by ASMI status

Table 2 shows the characteristics of the overall cohort, males, and females by their ASMI status. In the overall cohort, compared to those with normal ASMI, participants with low ASMI were older (74.30 years vs. 71.06 years), lighter (46.05 kg vs. 59.28 kg), with lower mid upper arm circumference (23.05 cm vs. 27.07 cm), calf circumference (30.47 cm vs. 34.94 cm), and bone mass (1.93 kg vs. 2.37 kg) (all P < 0.0001). There was a significant association between ASMI status and vitamin D status (P = 0.0472). Participants with low ASMI were likely to have vitamin D deficiency compared to those with normal ASMI (13.02% vs. 18.52%; P = 0.0144, data not shown). In addition, participants with low ASMI were almost twice as likely to have been admitted to the hospital within the prior 6 months (9.62% vs. 5.74%; P = 0.0190) and had significantly lower PASE scores (103.3 vs. 121.5; P < 0.0001). There was a significant difference in education level between the older adults with normal ASMI and low ASMI (P < 0.0001), with the latter having a higher percentage with no formal education (35.07% vs. 20.13%). Supplementary Table 2 shows the characteristics of older adults by their ASMI and nutritional status.

Table 2 Characteristics of all participants.

Overall (n = 1129)

Males (n = 456)

Females (n = 673)

Normal ASMI

(N = 453)

Low ASMI

(N = 676)

P value

Normal ASMI

(N = 196)

Low ASMI

(N = 260)

P value

Normal ASMI

(N = 257)

Low ASMI

(N = 416)

P value

Appendicular skeletal muscle mass index (kg/m2)

7.02 (1.07)

5.55 (0.70)

< 0.0001

7.97 (0.78)

6.21 (0.54)

< 0.0001

6.30 (0.59)

5.13 (0.41)

< 0.0001

Appendicular skeletal muscle mass (kg)

17.82 (4.24)

13.75 (2.90)

< 0.0001

21.95 (2.75)

16.69 (2.08)

< 0.0001

14.67 (1.73)

11.91 (1.48)

< 0.0001

Age (year)

71.06 (5.13)

74.30 (7.25)

< 0.0001

71.24 (5.29)

74.72 (6.93)

< 0.0001

70.93 (5.01)

74.03 (7.43)

< 0.0001

Ethnicity, n (%)

0.8652

0.8891

0.8230

Chinese

385 (84.99)

577 (85.36)

155 (79.08)

207 (79.62)

230 (89.49)

370 (88.94)

Non-Chinese

68 (15.01)

99 (14.64)

41 (20.92)

53 (20.38)

27 (10.51)

46 (11.06)

Highest level of education, n (%)

< 0.0001

< 0.0001

0.0029

No formal education/primary

91 (20.13)

236 (35.07)

28 (14.29)

83 (31.92)

63 (24.61)

153 (37.05)

Secondary O/N level or equivalent

198 (43.81)

278 (41.31)

81 (41.33)

102 (39.23)

117 (45.70)

176 (42.62)

A level or equivalent

106 (23.45)

106 (15.75)

54 (27.55)

52 (20.00)

52 (20.31)

54 (13.08)

University and above

57 (12.61)

53 (7.88)

33 (16.84)

23 (8.85)

24 (9.38)

30 (7.26)

Smoking status, n (%)

0.0004

< 0.0001

0.1133

Non-smoker

375 (82.78)

521 (77.07)

129 (65.82)

129 (49.62)

246 (95.72)

392 (94.23)

Past smoker

65 (14.35)

96 (14.20)

56 (28.57)

85 (32.69)

9 (3.50)

11 (2.64)

Daily/Occasional smoker

13 (2.87)

59 (8.73)

11 (5.61)

46 (17.69)

2 (0.78)

13 (3.13)

Alcohol consumption, n (%)

0.0263

0.0304

0.4032

Non-drinker

258 (68.80)

423 (74.87)

88 (57.89)

126 (62.07)

170 (76.23)

297 (82.04)

No drinks in last 12 months

78 (17.22)

111 (16.42)

44 (22.45)

57 (21.92)

34 (13.23)

54 (12.98)

< Once a month in last 12 months

76 (20.27)

73 (12.92)

37 (24.34)

26 (12.81)

39 (17.49)

47 (12.98)

≥ Once a month in last 12 months

41 (10.93)

69 (12.21)

27 (17.76)

51 (25.12)

14 (6.28)

18 (4.97)

Current marital status, n (%)

0.0001

0.0025

0.0511

Never married

49 (10.82)

110 (16.27)

13 (6.63)

34 (13.08)

36 (14.01)

76 (18.27)

Currently married

325 (71.74)

402 (59.47)

167 (85.20)

186 (71.54)

158 (61.48)

216 (51.92)

Separated/Divorced/Widowed

79 (17.44)

164 (24.26)

16 (8.16)

40 (15.38)

63 (24.51)

124 (29.81)

Hospital admission in last 6 months, n (%)

0.0190

0.1534

0.0373

Yes

26 (5.74)

65 (9.62)

16 (8.16)

32 (12.31)

10 (3.89)

33 (7.93)

No

427 (94.26)

611 (90.38)

180 (91.84)

228 (87.69)

247 (96.11)

383 (92.07)

Days admitted in hospital last 6 months

0.37 (1.90)

0.78 (3.84)

0.0272

0.59 (2.35)

0.93 (4.04)

0.2315

0.21 (1.45)

0.68 (3.70)

0.0343

Number of prescribed drugs, n (%)

0.7464

0.0713

0.2551

Nil (0)

110 (24.28)

177 (26.18)

42 (21.43)

68 (26.15)

68 (26.46)

109 (26.20)

One to five

262 (57.84)

385 (56.95)

105 (53.57)

149 (57.31)

157 (61.09)

236 (56.73)

More than five (> 5)

81 (17.88)

114 (16.86)

49 (25.00)

43 (16.54)

32 (12.45)

71 (17.07)

Physical Activity Scale for the Elderly score

121.52 (65.36)

103.25 (62.09)

< 0.0001

125.97 (73.24)

106.87 (69.15)

0.0046

118.13 (58.57)

100.99 (57.22)

0.0002

Modified Barthel Index score

99.37 (3.33)

98.63 (6.85)

0.2206

99.36 (2.97)

99.21 (5.32)

0.5176

99.37 (3.59)

98.27 (7.63)

0.0488

Total Charlson Comorbidity score

0.04 (0.24)

0.07 (0.29)

0.0724

0.06 (0.31)

0.10 (0.35)

0.1416

0.02 (0.15)

0.05 (0.23)

0.2219

25-hydroxyvitamin D (ug/L)

29.90 (9.80)

28.92 (9.63)

0.0989

32.01 (10.20)

30.12 (9.93)

0.0478

28.29 (9.17)

28.18 (9.38)

0.8837

25-hydroxyvitamin D (ug/L), n (%)

0.0472

0.0685

0.2472

Deficient < 20 ug/L

59 (13.02)

125 (18.52)

16 (8.16)

39 (15.06)

43 (16.73)

86 (20.67)

Insufficient 20- < 30 ug/L

192 (42.38)

262 (38.81)

78 (39.80)

102 (39.38)

114 (44.36)

160 (38.46)

Sufficient 30–100 ug/L

202 (44.59)

288 (42.67)

102 (52.04)

118 (45.56)

100 (38.91)

170 (40.87)

Height (cm)

158.26 (8.77)

156.59 (8.75)

0.0017

165.76 (5.72)

163.70 (6.73)

0.0005

152.54 (5.92)

152.14 (6.68)

0.4185

Body weight (kg)

59.28 (11.06)

46.05 (6.78)

< 0.0001

65.36 (9.78)

49.91 (6.04)

< 0.0001

54.65 (9.65)

43.64 (6.08)

< 0.0001

BMI (kg/m2)

23.59 (3.54)

18.73 (1.97)

< 0.0001

23.75 (3.09)

18.60 (1.74)

< 0.0001

23.46 (3.85)

18.82 (2.10)

< 0.0001

Mid upper arm circumference (cm)

27.07 (3.58)

23.05 (2.46)

< 0.0001

27.72 (3.20)

23.66 (2.23)

< 0.0001

26.58 (3.78)

22.67 (2.52)

< 0.0001

Calf circumference (cm)

34.94 (3.22)

30.47 (2.69)

< 0.0001

35.95 (3.07)

31.42 (2.25)

< 0.0001

34.17 (3.12)

29.88 (2.78)

< 0.0001

Bone mass (kg)

2.37 (0.41)

1.93 (0.39)

< 0.0001

2.71 (0.27)

2.25 (0.24)

< 0.0001

2.11 (0.29)

1.73 (0.32)

< 0.0001

BMI body mass index, O/N level ordinary/normal level, A level advanced level. For continuous variables, results are presented as mean (standard deviation). For categorical variables, results are presented as number (%).

Factors associated with ASMI

As shown in Table 3, in the overall cohort, factors associated with ASMI included age, gender, calf circumference, bone mass, and nutritional status. For every one-year increase in age while holding other factors constant, ASMI was significantly lower by − 0.011 (95% CI − 0.017, − 0.005). Females had significantly lower ASMI than males (− 0.792, 95% CI − 0.891, − 0.694). Compared to older adults with normal nutritional status, ASMI was significantly lower among those at medium risk (− 0.373, 95% CI − 0.460, − 0.286) and high risk (− 0.608, 95% CI − 0.713, − 0.503) of malnutrition. On the other hand, calf circumference and bone mass were positively associated with ASMI (both P < 0.0001). In addition, for both males and females, age and risk of malnutrition were negatively associated with ASMI, whereas calf circumference and bone mass were positively associated with ASMI (all P ≤ 0.0139).

Table 3 Factors associated with ASMI using multiple linear regression models: overall cohort, males and females.

Overall Cohort (n = 1211)

Males (n = 504)

Females (n = 707)

Estimate (Beta)

Std. error

95% CI

P value

Estimate (Beta)

Std. error

95% CI

P value

Estimate (Beta)

Std. Error

95% CI

P value

Intercept

3.374

0.351

(2.685, 4.063)

< 0.0001

1.000

0.534

(− 0.050, 2.051)

0.0618

3.488

0.400

(2.702, 4.274)

< 0.0001

Age (year)

− 0.011

0.003

(− 0.017, − 0.005)

0.0002

− 0.011

0.004

(− 0.019, − 0.002)

0.0139

− 0.010

0.004

(− 0.016, − 0.003)

0.0059

Gender

< 0.0001

Male (ref)

0

Female

− 0.792

0.050

(− 0.891, − 0.694)

Ethnicity

0.1591

0.3413

0.0237

Chinese (ref)

0

0

0

Non-Chinese

0.067

0.047

(− 0.026, 0.160)

− 0.060

0.063

(− 0.183, 0.063)

0.147

0.065

(0.020, 0.274)

Smoking

0.1595

0.6716

0.0566

Non-smoker (ref)

0

0

0

Past smoker

0.039

0.053

(− 0.065, 0.143)

0.050

0.059

(− 0.065, 0.165)

0.243

0.112

(0.022, 0.463)

Daily/Occasional smoker

− 0.112

0.071

(− 0.252, 0.028)

0.037

0.080

(− 0.120, 0.193)

− 0.130

0.134

(− 0.393, 0.133)

Drinking

0.0509

0.0612

0.4182

Non-drinker (ref)

0

0

0

No drinks in last 12 months

− 0.070

0.046

(− 0.160, 0.020)

− 0.0178

0.0655

(− 0.147, 0.111)

− 0.055

0.058

(− 0.168, 0.059)

< Once a month in last 12 months

− 0.106

0.051

(− 0.205, − 0.007)

− 0.188

0.077

(− 0.340, − 0.036)

− 0.077

0.059

(− 0.193, 0.039)

≥ Once a month in last 12 months

− 0.123

0.059

(− 0.238, − 0.008)

− 0.1145

0.0717

(− 0.255, 0.027)

− 0.092

0.092

(− 0.272, 0.088)

Marital status

0.8135

0.6322

0.8732

Currently married (ref)

0

0

0

Separated/Divorced/Widowed

0.026

0.043

(− 0.059, 0.111)

0.074

0.077

(− 0.078, 0.226)

− 0.014

0.048

(− 0.107, 0.080)

Never married

− 0.004

0.048

(− 0.099, 0.090)

0.007

0.082

(− 0.154, 0.167)

0.019

0.054

(− 0.087, 0.124)

Education

0.1081

0.0606

0.0690

No formal education/primary (ref)

0

0

0

Secondary O/N level or equivalent

− 0.064

0.041

(− 0.145, 0.017)

0.093

0.066

(− 0.036, 0.222)

− 0.099

0.048

(− 0.193, − 0.005)

A level or equivalent

− 0.098

0.050

(− 0.197, 0.000)

− 0.050

0.074

(− 0.196, 0.095)

− 0.110

0.061

(− 0.231, 0.010)

University and above

− 0.135

0.063

(− 0.259, − 0.011)

− 0.075

0.090

(− 0.252, 0.102)

− 0.180

0.079

(− 0.335, − 0.025)

Physical Activity Scale for the Elderly score

0.0003

0.0003

(− 0.0002, 0.0009)

0.2184

0.0003

0.0004

(− 0.0004, 0.0010)

0.4675

0.0004

0.0004

(− 0.0003, 0.0011)

0.2699

Calf circumference (cm)

0.085

0.007

(0.071, 0.099)

< 0.0001

0.123

0.011

(0.101, 0.145)

< 0.0001

0.066

0.008

(0.050, 0.082)

< 0.0001

Bone mass (kg)

0.778

0.067

(0.646, 0.909)

< 0.0001

1.193

0.112

(0.972, 1.414)

< 0.0001

0.542

0.076

(0.393, 0.690)

< 0.0001

MUST risk category

< 0.0001

< 0.0001

< 0.0001

Low (ref)

0

0

0

Medium

− 0.373

0.044

(− 0.460, − 0.286)

− 0.388

0.068

(− 0.521, − 0.255)

− 0.298

0.052

(− 0.401, − 0.195)

High

− 0.608

0.054

(− 0.713, − 0.503)

− 0.579

0.084

(− 0.744, − 0.415)

− 0.554

0.062

(− 0.676, − 0.432)

O/N level ordinary/normal level, A level advanced level, MUST Malnutrition universal screening test.

Factors associated with low ASMI

Multiple logistic regression model showed that factors associated with low ASMI included age, smoking, drinking, calf circumference, bone mass, and nutritional status (Table 4). With every one-year increase in age, the odds of having low ASMI increased by 6% (odds ratio: 1.06, 95% CI 1.02, 1.09). Compared to non-smoker, daily or occasional smokers had significantly higher odds of having low ASMI (odds ratio: 3.76, 95% CI 1.55, 9.16). The odds of having low ASMI for older adults who drank at least once a month was 2.51 (95% CI 1.34, 4.67), compared to non-drinkers. Calf circumference and bone mass were associated with lower odds of having low ASMI (both P < 0.0001). Compared to older adults with normal nutritional status, the odds ratio of having low ASMI was 3.58 (95% CI 2.41, 5.30) among those at medium risk of malnutrition, and 12.50 (95% CI 7.02, 22.25) among those at high risk of malnutrition. In addition, for both males and females, calf circumference and bone mass were associated with lower odds of having low ASMI (all P < 0.0001). On the other hand, malnutrition risk was associated with higher odds of having low ASMI in both genders (both P < 0.0001), and age for females only (P = 0.0425).

Table 4 Factors associated with low ASMI using multiple logistic regression models: overall cohort, males and females.

Overall Cohort (n = 1211)

Males (n = 504)

Females (n = 707)

Odds ratio

95% CI

P value

Odds ratio

95% CI

P value

Odds ratio

95% CI

P value

Age (year)

1.06

(1.02, 1.09)

0.0011

1.00

(0.94, 1.06)

0.9019

1.05

(1.00, 1.09)

0.0425

Ethnicity

0.3151

0.5679

0.7929

Chinese (ref)

1.00

1.00

1.00

Non-Chinese

1.31

(0.77, 2.22)

1.30

(0.53, 3.21)

0.90

(0.40, 2.01)

Smoking

0.0134

0.4439

0.8041

Non-smoker (ref)

1.00

1.00

1.00

Past smoker

1.18

(0.69, 2.03)

0.74

(0.34, 1.61)

0.83

(0.22, 3.10)

Daily/Occasional smoker

3.76

(1.55, 9.16)

1.81

(0.51, 6.42)

1.94

(0.22, 16.97)

Drinking

0.0328

0.2856

0.3608

Non-drinker (ref)

1.00

1.00

1.00

No drinks in last 12 months

1.40

(0.86, 2.26)

0.88

(0.38, 2.04)

1.64

(0.85, 3.15)

< Once a month in last 12 months

1.28

(0.74, 2.21)

1.29

(0.44, 3.81)

1.49

(0.76, 2.95)

≥ Once a month in last 12 months

2.51

(1.34, 4.67)

2.35

(0.87, 6.36)

1.48

(0.54, 4.04)

Marital status

0.4346

0.9584

0.9713

Currently married (ref)

1.00

1.00

1.00

Separated/Divorced/Widowed

0.74

(0.46, 1.17)

1.10

(0.35, 3.47)

0.94

(0.54, 1.62)

Never married

0.92

(0.55, 1.56)

0.87

(0.27, 2.84)

0.95

(0.51, 1.80)

Education

0.2757

0.2228

0.0914

No formal education/primary (ref)

1.00

1.00

1.00

Secondary O/N level or equivalent

1.22

(0.78, 1.90)

0.84

(0.35, 2.04)

1.34

(0.77, 2.32)

A level or equivalent

1.00

(0.59, 1.71)

2.03

(0.73, 5.61)

0.71

(0.36, 1.40)

University and above

1.80

(0.94, 3.47)

1.74

(0.56, 5.35)

2.03

(0.83, 4.97)

Physical Activity Scale for the Elderly score

0.999

(0.996, 1.001)

0.3094

0.998

(0.993, 1.003)

0.3716

0.998

(0.993, 1.002)

0.2311

Calf circumference (cm)

0.72

(0.66, 0.78)

< 0.0001

0.69

(0.59, 0.82)

< 0.0001

0.73

(0.66, 0.81)

< 0.0001

Bone mass (kg)

0.26

(0.15, 0.47)

< 0.0001

0.01

(0.00, 0.04)

< 0.0001

0.12

(0.05, 0.30)

< 0.0001

MUST risk category

< 0.0001

< 0.0001

< 0.0001

Low (ref)

1.00

1.00

1.00

Medium

3.58

(2.41, 5.31)

5.69

(2.71, 11.96)

2.24

(1.36, 3.72)

High

12.50

(7.02, 22.25)

14.18

(4.73, 42.56)

8.54

(4.16, 17.55)

O/N level ordinary/normal level, A level advanced level, MUST malnutrition universal screening test.

Calf circumference cut-offs

The cut-off values of calf circumference for low ASMI for males was 33.4 cm (sensitivity = 82%, specificity = 82%) and for females was 32.2 cm (sensitivity = 82%, specificity = 74%). As shown in Fig. 2, the area under the ROC curve for males was 0.8988, and for females was 0.8580. The Kappa statistics showed strong agreement between the cut-off values of calf circumference for low ASMI derived from this study and the cut-off values for screening for sarcopenia as recommended by the AWGS (males = 0.88, females = 0.87; both P < 0.0001).

Graph: Figure 2 Receiver operating characteristic curves of calf circumference for low muscle mass in (a) males; and (b) females.

Discussion

To our knowledge, this is a first-of-kind study that determined the prevalence of low ASMI and its associated factors in community-dwelling, ambulant older adults. The findings of our study revealed that low ASMI was especially common among this cohort. We further identified factors that were associated with increased risk for low ASMI, i.e., age, malnutrition or its risk, smoking, alcohol consumption, low calf circumference, and low bone mass. These findings can be used to promote public health programs that can help older adults restore and maintain physical function, thus sustaining independent living in the community.

Gender

Men are known to have more muscle mass than women, both in terms of absolute amount as well as in relation to overall composition[9]. This is predominantly due to the difference in muscle mass in the upper body. However, both genders experienced the same decline in muscle mass with aging, which is noticeable after the fifth decade[9]. The literature has also reported gender-specific differences in mid-upper arm circumference[38], calf circumference[39], and ASMI[1],[2]. These differences between genders are also reflected in the present study.

Older age

Older age was a key factor in predicting low ASMI. Our findings showed that there was a 6% increase in the odds of having low ASMI for every year older above 65. While age is a non-modifiable risk factor, it serves as an important marker for low ASMI.

This association between age and low ASMI is also reflected in the association between age and sarcopenia[40],[41]. This is because low muscle mass is one of the diagnostic criteria for sarcopenia. In fact, researchers associated the highest likelihood of sarcopenia in the oldest old[5],[42], with older adults aged ≥ 70 years reported to lose up to 15% of muscle mass every decade[43]. In addition, participants aged ≥ 80 years were six times more likely to be at risk of sarcopenia as compared to those aged 60–80 years[40]. This finding is reflected in results from a Singapore study, which showed that more than one in two older adults above 80 years old will be at risk of losing at least one instrumental activity of daily living and adversely affect the ability to live independently[44].

Risk of malnutrition

In our study, low ASMI was significantly and prominently correlated with poor nutritional status. The odds of having low ASMI for older adults at high risk of malnutrition was 12.5 compared to their nourished counterparts, after adjusting for potential confounders. In fact, low muscle mass is now considered a defining characteristic of malnutrition[45]. The association between low muscle mass and malnutrition has been reported in the literature[46]–[48]. According to Landi et al., malnutrition needs to be addressed clinically as a muscle-related disorder, and clinicians should integrate nutrition assessment with muscle mass measurements for optimal evaluation of these two interrelated entities[48]. In parallel, Deutz et al. advised clinicians to place muscle mass at the core of nutrition assessment and management strategies[47].

Our findings of low muscle mass are also in line with a recent study, which reported that older adults with malnutrition or at risk of malnutrition were 13.6 times more likely to be at risk of sarcopenia, compared to those with normal nutritional status[40]. In another study of community-dwelling older adults in Singapore, risk of malnutrition was strongly associated with sarcopenia (odds ratio = 9.9)[49]. Similarly, a cohort study found that malnutrition was associated with an approximately four-fold higher risk of sarcopenia developing during a four-year follow-up[50]. Community-dwelling older Chinese adults with malnutrition experienced adverse outcomes such as sarcopenia, frailty, and mortality at 14-year follow-up[51].

These observations suggest that assessing the risk for malnutrition in community-dwelling older adults could be a useful strategy for early detection of individuals at risk of low ASMI. Validated tools such as MUST and Mini Nutritional Assessment - Short Form can be used to assess the risk of malnutrition[52],[53].

Bone mass

Our findings of a direct correlation between low ASMI and low bone mass in older people are also in line with other studies in this area[54],[55]. Specifically, in a Chinese population, leg lean mass was the strongest factor for prediction of femur bone mass[54]. Reduction in muscle strength over time was found to be the most significant independent factor associated with bone loss for Korean men and women[56]. Taken together, all these findings are in line with the established link between skeletal muscle and bone health.

Lifestyle-related risk factors

In the present study, we found that people with low ASMI had lower physical activity scores than those with normal ASMI. In addition, smoking and drinking were associated with low ASMI. Previous research reported that lifestyle-related risks for low muscle mass include physical inactivity[20], smoking[21], and drinking[14]. Low physical activity leads to muscle decline due to disuse atrophy[57],[58]. Smoking may impair muscle protein synthesis, while chronic alcoholic myopathy can occur in up to 50% of alcohol misusers leading to reduction of muscle mass and strength[59]. All three of these factors are potentially modifiable, so risk can be lessened by increasing physical activity, smoking cessation, and reducing alcohol consumption.

Calf circumference cut-off values for low ASMI

Previous research showed that low muscle mass was significantly associated with low calf circumference in older people[60]–[62]. In the present study, we used ROC curve analysis to determine calf circumference cut-off values for low ASMI, i.e., 33.4 cm for males and 32.2 cm for females. A previous study found that calf circumference was positively correlated with appendicular skeletal muscle mass and skeletal muscle index, with cut-off values of calf circumference for predicting low muscle mass as < 34 cm in men and < 33 cm in women in a large study in Japan (n = 526)[60]. Similarly, a large study of older adults in Korea (n = 657 adults aged 70–84 years) found optimal cut-off values of calf circumference for low muscle mass as 35 cm for males and 33 cm for females[61]. Importantly, low calf circumference based on these cut-off values was associated with poor physical function[61]. Overall, these findings are in line with the calf circumference cut-offs for screening for sarcopenia from AWGS (< 34 cm in men and < 33 cm in women)[1], thus supporting calf measurement as a screening tool for both low ASMI and sarcopenia in the community.

In the community, initial screening for low muscle mass can be done by measuring calf circumference[60]–[62]. We have established the cut-off values for low ASMI in community-dwelling older adults in Singapore, with strong agreement with the AWGS cut-off values for screening for sarcopenia (Kappa statistics for males = 0.88, for females = 0.87). As the measurement of calf circumference is low cost, easy to perform, and non-invasive, it can potentially be an ideal screening tool both in the community and clinical settings.

Strengths and limitations

Our study has multiple strengths in design and outcomes, including (1) a large population of 1211 community-dwelling older adults, (2) extensive data with a full picture of interacting factors, (3) observation of significant associations between risk of malnutrition and low ASMI after adjusting for potential confounders, and (4) establishment of gender-specific calf circumference cut-off values for low ASMI. As for limitations, this is a cross-sectional study, so it shows associations between low ASMI and certain health and demographic factors, but it does not prove causal relationship. Since our population size was substantial, and these associations were statistically significant, we propose that healthcare professionals use these findings to identify aging individuals at risk of low ASMI. In addition, the results of this study in the multiethnic Singapore population may be applicable to other Asian populations.

Conclusions

In conclusion, results of our study showed a high prevalence of low ASMI in community-dwelling older adults in Singapore, particularly among those at risk of malnutrition. The odds of having low ASMI was 12.5 for older adults at high risk of malnutrition compared to their nourished counterparts. For community-dwelling older adults, early identification of low muscle mass offers opportunities to prevent or delay its worsening, and its associated adverse consequences. We advise identification of malnutrition risk as a targeted core strategy to screen for low muscle mass in older adults.

Other risk factors included smaller calf circumference, older age, and lower bone mass, which were also significantly associated with risk of low ASMI. We have also determined gender-specific cut-off values of calf circumference for low ASMI in this population group and may thus serve as an easy-to-measure screening tool for low ASMI. Furthermore, low ASMI was associated with modifiable risk factors such as smoking and drinking, which suggests that current targeted community health promotion programs can improve muscle health, in addition to other established benefits.

Early identification of risk for low ASMI in older adults can guide appropriate interventions, which can in turn reduce associated health complications, lower healthcare costs, improve function and quality of life, and thus supporting healthier, more independent and meaningful lives for as long as possible.

Acknowledgements

We would like to thank the participants for their commitment and enthusiasm in participating in this study. This study would not have been possible without all the invaluable contributions, dedication and commitment from all the co-investigators, study teams of Abbott Nutrition, Changi General Hospital, and SingHealth Polyclinics. We also thank Cecilia Hofmann, medical writer, C. Hofmann & Associates (Western Springs, Illinois, USA) for her editorial support.

Author contributions

S.L.T., D.T.T.H., G.B., C.H.H., Y.L.L., M.C., W.L.C., N.C.T., and S.T.H.C. conceptualized the study. Y.B., G.B., and S.L.T. analyzed the data. S.L.T. curated the data. S.L.T. and S.T.H.C. drafted the manuscript. All authors reviewed and approved the manuscript.

Funding

This study received financial support from the Economic Development Board of Singapore (Grant number: COY-15-IDS-LL/160011), Abbott Nutrition Research and Development, and Changi General Hospital. The Economic Development Board of Singapore had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. Abbott Nutrition Research and Development and Changi General Hospital were involved in the study design, data collection and analysis, or preparation of the manuscript.

Data availability

The data presented in this study are available within the paper and its Supplementary Dataset.

Competing interests

S.L.T., D.T.T.H., G.B., and Y.L.L. are employees of Abbott. Y.B. is an employee of Cognizant Technologies Solution Pvt. Ltd., a Contract Research Organization, which provides statistical services to Abbott Nutrition and has no competing interests. S.T.H.C. reports receiving honoraria for speaking engagement from Abbott. All other authors declare no competing interests.

Supplementary Information

Graph: Supplementary Information.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1038/s41598-021-02274-3.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References 1 Chen L-K. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 2020; 21: 300-307. 10.1016/j.jamda.2019.12.012. 32033882 2 Cruz-Jentoft AJ. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48: 16-31. 10.1093/ageing/afy169. 30312372 3 Prado CM. Implications of low muscle mass across the continuum of care: a narrative review. Ann. Med. 2018; 50: 675-693. 10.1080/07853890.2018.1511918. 30169116 4 Kim M, Kim J, Won CW. Association between involuntary weight loss with low muscle mass and health-related quality of life in community-dwelling older adults: Nationwide surveys (KNHANES 2008–2011). Exp. Gerontol. 2018; 106: 39-45. 10.1016/j.exger.2018.02.027. 29499371 5 Pang BWJ. Prevalence and associated factors of sarcopenia in Singaporean adults - The Yishun Study. J. Am. Med. Dir. Assoc. 2021; 22; 885: e881-885.e810. 10.1016/j.jamda.2020.05.029 6 Tey SL. Factors associated with muscle mass in community-dwelling older people in Singapore: findings from the SHIELD study. PLoS ONE. 2019; 14. 1:CAS:528:DC%2BC1MXit1WisLbI. 10.1371/journal.pone.0223222. 31596873. 6785067 7 Xu H-Q. Sarcopenia-related features and factors associated with low muscle mass, weak muscle strength, and reduced function in Chinese rural residents: a cross-sectional study. Arch. Osteoporos. 2019; 14: 2. 10.1007/s11657-018-0545-2 8 Zhang Y. Prevalence and risk factors governing the loss of muscle function in elderly sarcopenia patients: a longitudinal study in China with 4 years of follow-up. J. Nutr. Health Aging. 2020; 24: 518-524. 1:STN:280:DC%2BB38vgvVahsw%3D%3D. 10.1007/s12603-020-1361-0. 32346691 9 Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J. Appl. Physiol. 2000; 89: 81-88. 1:STN:280:DC%2BD3cvgsVGqtw%3D%3D. 10.1152/jappl.2000.89.1.81. 10904038 Auyeung TW, Lee SW, Leung J, Kwok T, Woo J. Age-associated decline of muscle mass, grip strength and gait speed: a 4-year longitudinal study of 3018 community-dwelling older Chinese. Geriatr. Gerontol. Int. 2014; 14; Suppl 1: 76-84. 10.1111/ggi.12213. 24450564 Boutari C, Mantzoros CS. Decreasing lean body mass with age: challenges and opportunities for novel therapies. Endocrinol. Metab. (Seoul). 2017; 32: 422-425. 1:CAS:528:DC%2BC1MXjsVKqu74%3D. 10.3803/EnM.2017.32.4.422 Goodpaster BH. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 2006; 61: 1059-1064. 10.1093/gerona/61.10.1059. 17077199 Kim S-K. Changes in body composition according to age and sex among young non-diabetic Korean adults: The Kangbuk Samsung Health Study. Endocrinol Metab. 2017; 32: 442-450. 10.3803/EnM.2017.32.4.442 Tyrovolas S. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study. J Cachexia Sarcopenia Muscle. 2016; 7: 312-321. 10.1002/jcsm.12076. 27239412 Swan L, Warters A, O'Sullivan M. Socioeconomic inequality and risk of sarcopenia in community-dwelling older adults. Clin. Interv. Aging. 2021; 16: 1119-1129. 10.2147/CIA.S310774. 34168435. 8216634 Kim K-S. Type 2 diabetes is associated with low muscle mass in older adults. Geriatr. Gerontol. Int. 2014; 14: 115-121. 10.1111/ggi.12189. 24450569 Barreiro E, Jaitovich A. Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets. J. Thorac. Dis. 2018; 10: S1415-S1424. 10.21037/jtd.2018.04.168 Welch C, Hassan-Smith Z, Greig C, Lord J, Jackson T. Acute sarcopenia secondary to hospitalisation—an emerging condition affecting older adults. Aging Dis. 2018; 9: 151-164. 10.14336/AD.2017.0315. 29392090. 5772853 Ilhan B, Bahat G, Erdogan T, Kilic C, Karan MA. Anorexia Is independently associated with decreased muscle mass and strength in community dwelling older adults. J. Nutr. Health Aging. 2019; 23: 202-206. 10.1007/s12603-018-1119-0. 30697631 Kwon Y-J, Kim HS, Jung D-H, Kim J-K. Cluster analysis of nutritional factors associated with low muscle mass index in middle-aged and older adults. Clin. Nutr. 2020; 39: 3369-3376. 1:CAS:528:DC%2BB3cXkvFChsrs%3D. 10.1016/j.clnu.2020.02.024. 32192777 Bai H-J. Age-related decline in skeletal muscle mass and function among elderly men and women in Shanghai, China: a cross sectional study. Asia Pac. J. Clin. Nutr. 2016; 25: 326-332. 10.6133/apjcn.2016.25.2.14. 27222416 Franzon K, Zethelius B, Cederholm T, Kilander L. The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men. BMC Geriatr. 2019; 19: 153. 10.1186/s12877-019-1142-y. 31142271. 6542054 Wakayama S. Skeletal muscle mass and higher-level functional capacity in female community-dwelling older adults. Int. J. Environ. Res. Public Health. 2021; 18: 6692. 10.3390/ijerph18136692 Norman K, Otten L. Financial impact of sarcopenia or low muscle mass—a short review. Clin. Nutr. 2019; 38: 1489-1495. 10.1016/j.clnu.2018.09.026. 30316536 Lo Y-TC. Medical costs of a low skeletal muscle mass are modulated by dietary diversity and physical activity in community-dwelling older Taiwanese: a longitudinal study. Int. J. Behav. Nutr. Phys. Act. 2017; 14: 31. 10.1186/s12966-017-0487-x. 28288651. 5348879 Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 2004; 52: 80-85. 10.1111/j.1532-5415.2004.52014.x. 14687319 Goates S. Economic impact of hospitalizations in US adults with sarcopenia. J. Frailty Aging. 2019; 8: 93-99. 1:STN:280:DC%2BB3M%2FmslWquw%3D%3D. 10.14283/jfa.2019.10. 30997923 United Nations. World Population Ageing 2019: Highlights. (Department of Economic and Social Affairs, Population Division, 2019). Cheong M. Nutritional biomarkers and associated factors in community-dwelling older adults: Findings from the SHIELD study. Nutrients. 2020; 12: 3329. 1:CAS:528:DC%2BB3cXisFKqsbbM. 10.3390/nu12113329. 7693785 Chew STH. Impact of specialized oral nutritional supplement on clinical, nutritional, and functional outcomes: a randomized, placebo-controlled trial in community-dwelling older adults at risk of malnutrition. Clin. Nutr. 2021; 40: 1879-1892. 1:CAS:528:DC%2BB3cXitFCksbnE. 10.1016/j.clnu.2020.10.015. 33268143 Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J. Clin. Epidemiol. 1994; 47: 1245-1251. 1:STN:280:DyaK2M3jvFantQ%3D%3D. 10.1016/0895-4356(94)90129-5. 7722560 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987; 40: 373-383. 1:STN:280:DyaL2s7ms1GnsQ%3D%3D. 10.1016/0021-9681(87)90171-8. 3558716 Stratton RJ. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the 'Malnutrition Universal Screening Tool' ('MUST') for adults. Br. J. Nutr. 2004; 92: 799-808. 1:CAS:528:DC%2BD2cXhtVCjsbvK. 10.1079/bjn20041258. 15533269 Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The Physical Activity Scale for the Elderly (PASE): evidence for validity. J. Clin. Epidemiol. 1999; 52: 643-651. 1:STN:280:DyaK1MzhvVGnsA%3D%3D. 10.1016/S0895-4356(99)00049-9. 10391658 Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J. Clin. Epidemiol. 1993; 46: 153-162. 1:STN:280:DyaK3s7ntF2rug%3D%3D. 10.1016/0895-4356(93)90053-4. 8437031 Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J. Clin. Epidemiol. 1989; 42: 703-709. 1:STN:280:DyaL1MzktFylsg%3D%3D. 10.1016/0895-4356(89)90065-6. 2760661 Holick MF. Vitamin D deficiency. N. Engl. J. Med. 2007; 357: 266-281. 1:CAS:528:DC%2BD2sXotVejsbc%3D. 10.1056/NEJMra070553. 17634462 Hu FJ. Mid-upper arm circumference as an alternative screening instrument to appendicular skeletal muscle mass index for diagnosing sarcopenia. Clin. Interv. Aging. 2021; 16: 1095-1104. 10.2147/CIA.S311081. 34163153. 8214542 Hwang A-C, Liu L-K, Lee W-J, Peng L-N, Chen L-K. Calf circumference as a screening instrument for appendicular muscle mass measurement. J. Am. Med. Dir. Assoc. 2018; 19: 182-184. 10.1016/j.jamda.2017.11.016. 29306606 Sato PHR, Ferreira AA, Rosado EL. The prevalence and risk factors for sarcopenia in older adults and long-living older adults. Arch. Gerontol. Geriatr. 2020; 89. 10.1016/j.archger.2020.104089. 32388069 Therakomen V, Petchlorlian A, Lakananurak N. Prevalence and risk factors of primary sarcopenia in community-dwelling outpatient elderly: a cross-sectional study. Sci. Rep. 2020; 10: 19551. 2020NatSR.1019551T. 1:CAS:528:DC%2BB3cXitlClsrvO. 10.1038/s41598-020-75250-y. 33177536. 7658996 Martone AM. Treating sarcopenia in older and oldest old. Curr. Pharm. Des. 2015; 21: 1715-1722. 1:CAS:528:DC%2BC2MXks1ylur0%3D. 10.2174/1381612821666150130122032. 25633117 Grimby G, Saltin B. The ageing muscle. Clin. Physiol. 1983; 3: 209-218. 1:STN:280:DyaL3s3mtVaqtw%3D%3D. 10.1111/j.1475-097x.1983.tb00704.x. 6347501 Chan, A. et al. Transitions in Health, Employment, Social Engagement And Intergenerational Transfers In Singapore Study (THE SIGNS Study) – I: Descriptive Statistics and Analysis of Key Aspects of Successful Ageing: 1–224. Duke-NUS Medical School Centre for Ageing Research and Education, Singapore. https://doi.org/10.25722/w8ye-r177 (2018). Cederholm T. GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community. Clin. Nutr. 2019; 38: 1-9. 1:STN:280:DC%2BB3c3lsVWjtQ%3D%3D. 10.1016/j.clnu.2018.08.002. 30181091 Argilés JM, Campos N, Lopez-Pedrosa JM, Rueda R, Rodriguez-Mañas L. Skeletal muscle regulates metabolism via interorgan crosstalk: Roles in health and disease. J. Am. Med. Dir. Assoc. 2016; 17: 789-796. 10.1016/j.jamda.2016.04.019. 27324808 Deutz NEP. The underappreciated role of low muscle mass in the management of malnutrition. J. Am. Med. Dir. Assoc. 2019; 20: 22-27. 10.1016/j.jamda.2018.11.021. 30580819 Landi F. Muscle loss: the new malnutrition challenge in clinical practice. Clin. Nutr. 2019; 38: 2113-2120. 1:STN:280:DC%2BB3cnisVWhtA%3D%3D. 10.1016/j.clnu.2018.11.021. 30553578 Lu Y. Systemic and metabolic signature of sarcopenia in community-dwelling older adults. J. Gerontol. A Biol. Sci. Med. Sci. 2020; 75: 309-317. 1:CAS:528:DC%2BB3cXit1amt7%2FP. 10.1093/gerona/glz001. 30624690 Beaudart C. Malnutrition as a strong predictor of the onset of sarcopenia. Nutrients. 2019; 11: 2883. 10.3390/nu11122883. 6950107 Yeung SSY, Chan RSM, Kwok T, Lee JSW, Woo J. Malnutrition according to GLIM criteria and adverse outcomes in community-dwelling Chinese older adults: a prospective analysis. J. Am. Med. Dir. Assoc. 2021; 22: 1953-1959.e1954. 10.1016/j.jamda.2020.09.029. 33153909 Skipper A. Adult malnutrition (undernutrition) screening: An evidence analysis center systematic review. J. Acad. Nutr. Diet. 2020; 120: 669-708. 10.1016/j.jand.2019.09.010. 31866356 Skipper A. Position of the Academy of Nutrition and Dietetics: malnutrition (undernutrition) screening tools for all adults. J. Acad. Nutr. Diet. 2020; 120: 709-713. 10.1016/j.jand.2019.09.011. 31866359 Cheng Q. A cross-sectional study of loss of muscle mass corresponding to sarcopenia in healthy Chinese men and women: reference values, prevalence, and association with bone mass. J. Bone Miner. Metab. 2014; 32: 78-88. 10.1007/s00774-013-0468-3. 23620096 Kim BJ, Ahn SH, Kim HM, Lee SH, Koh JM. Low skeletal muscle mass associates with low femoral neck strength, especially in older Korean women: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Osteoporos. Int. 2015; 26: 737-747. 1:CAS:528:DC%2BC2cXhvFGjtbrK. 10.1007/s00198-014-2959-z. 25391247 Kim KM. Longitudinal changes in muscle mass and strength, and bone mass in older adults: Gender-specific associations between muscle and bone losses. J. Gerontol. A Biol. Sci. Med. Sci. 2018; 73: 1062-1069. 1:CAS:528:DC%2BC1MXhslCrsb3F. 10.1093/gerona/glx188. 29985994 Bell KE, von Allmen MT, Devries MC, Phillips SM. Muscle disuse as a pivotal problem in sarcopenia-related muscle loss and dysfunction. J. Frailty Aging. 2016; 5: 33-41. 1:STN:280:DC%2BC28fgsleisA%3D%3D. 10.14283/jfa.2016.78. 26980367 Oikawa SY, Holloway TM, Phillips SM. The impact of step reduction on muscle health in aging: Protein and exercise as countermeasures. Front. Nutr. 2019. 10.3389/fnut.2019.00075. 31179284. 6543894 Rom O, Kaisari S, Aizenbud D, Reznick A. Lifestyle and sarcopenia–etiology, prevention, and treatment. Rambam Maimonides Med. J. 2012; 3: 1-12. 10.5041/RMMJ.10091 Kawakami R. Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women. Geriatr. Gerontol. Int. 2015; 15: 969-976. 10.1111/ggi.12377. 25243821 Kim S. Calf circumference as a simple screening marker for diagnosing sarcopenia in older Korean adults: the Korean Frailty and Aging Cohort Study (KFACS). J. Korean Med. Sci. 2018; 33: e151. 10.3346/jkms.2018.33.e151. 29760608. 5944215 Maeda K, Koga T, Nasu T, Takaki M, Akagi J. Predictive accuracy of calf circumference measurements to detect decreased skeletal muscle mass and European Society for Clinical Nutrition and Metabolism-defined malnutrition in hospitalized older patients. Ann. Nutr. Metab. 2017; 71: 10-15. 1:CAS:528:DC%2BC2sXhsFSksrvJ. 10.1159/000478707. 28647743

By Siew Ling Tey; Dieu Thi Thu Huynh; Yatin Berde; Geraldine Baggs; Choon How How; Yen Ling Low; Magdalin Cheong; Wai Leng Chow; Ngiap Chuan Tan and Samuel Teong Huang Chew

Reported by Author; Author; Author; Author; Author; Author; Author; Author; Author; Author

Titel:
Prevalence of low muscle mass and associated factors in community-dwelling older adults in Singapore
Autor/in / Beteiligte Person: Yen Ling Low ; Cheong, Magdalin ; Siew Ling Tey ; Baggs, Geraldine ; Samuel Teong Huang Chew ; Ngiap Chuan Tan ; Wai Leng Chow ; Choon How How ; Dieu Thi Thu Huynh ; Berde, Yatin
Link:
Zeitschrift: Scientific Reports, Jg. 11 (2021), Heft 1, S. 1-13
Veröffentlichung: Nature Portfolio, 2021
Medientyp: unknown
ISSN: 2045-2322 (print)
Schlagwort:
  • Male
  • Aging
  • Sarcopenia
  • Science
  • Population
  • Nutritional Status
  • Risk Assessment
  • Article
  • Low muscle mass
  • Sex Factors
  • Reference Values
  • medicine
  • Calf circumference
  • Prevalence
  • Humans
  • Mass Screening
  • Muscle Strength
  • education
  • Muscle, Skeletal
  • Aged
  • Nutrition
  • Aged, 80 and over
  • education.field_of_study
  • Singapore
  • Multidisciplinary
  • Anthropometry
  • business.industry
  • Malnutrition
  • Odds ratio
  • Middle Aged
  • medicine.disease
  • Hospitalization
  • Cross-Sectional Studies
  • Geriatrics
  • Cohort
  • Body Composition
  • Linear Models
  • Medicine
  • Female
  • Independent Living
  • Medium Risk
  • business
  • Bioelectrical impedance analysis
  • Demography
Sonstiges:
  • Nachgewiesen in: OpenAIRE
  • Sprachen: English
  • Language: English
  • Rights: OPEN

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -